25-Hydroxyvitamin D, cholesterol, and ultraviolet irradiation

Metabolism: Clinical and Experimental

Volumn 57, Issue 6, 2008, Pages 741-748

  Carbone, Laura D ^a,b   Rosenberg, E William ^b   Tolley, Elizabeth A ^b   Holick, Michael F ^c   Hughes, Thomas A ^b   Watsky, Mitchell A ^b   Barrow, Karen D ^b   Chen, Tai C ^c   Wilkin, Nathaniel K ^b   Bhattacharya, Syamal K ^b   Dowdy, John C ^d   Sayre, Robert M ^b,d   Weber, Karl T ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Rapid Precision Testing Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYERGOCALCIFEROL; APOLIPOPROTEIN; APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSIMETRY; ERYTHEMA; FEMALE; FIELD EMISSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PARAMETER; PRIORITY JOURNAL; RADIATION DOSE; STATISTICAL SIGNIFICANCE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET IRRADIATION; VITAMIN BLOOD LEVEL; WHOLE BODY RADIATION;

ADULT; APOLIPOPROTEIN A-I; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPOPROTEIN(A); MALE; ULTRAVIOLET RAYS; VITAMIN D;

EID: 43849099334     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.01.011     Document Type: Article

References (43)

1. Holick M.F. McCollum Award Lecture, 1994: vitamin D-new horizons for the 21st century. Am J Clin Nutr 60 (1994) 619-630
2. Calvo M.S., Whiting S.J., and Barton C.N. Vitamin D intake: a global perspective of current status. J Nutr 135 (2005) 310-316
3. Looker A.C., Dawson-Hughes B., Calvo M.S., Gunter E.W., and Sahyoun N.R. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30 (2002) 771-777
4. Nesby-O'Dell S., Scanlon K.S., Cogswell M.E., Gillespie C., Hollis B.W., Looker A.C., et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 76 (2002) 187-192
5. Holick M.F. Vitamin D: a millenium perspective. J Cell Biochem 88 (2003) 296-307
6. Staples J.A., Ponsonby A.L., Lim L.L., and McMichael A.J. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ Health Perspect 111 (2003) 518-523
7. Ponsonby A.L., McMichael A., and van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181-182 (2002) 71-78
8. Holick M.F. Sunlight and vitamin D: both good for cardiovascular health. J Gen Intern Med 17 (2002) 733-735
9. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79 (2004) 362-371
10. Malabanan A., Veronikis I.E., and Holick M.F. Redefining vitamin D insufficiency. Lancet 351 (1998) 805-806
11. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7 (1997) 439-443
12. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., and Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 16 (2005) 713-716
13. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22 (2001) 477-501
14. Matsuoka L.Y., Wortsman J., Haddad J.G., Kolm P., and Hollis B.W. Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol 127 (1991) 536-538
15. Tangpricha V., Turner A., Spina C., Decastro S., Chen T.C., and Holick M.F. Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr 80 (2004) 1645-1649
16. Ballantyne C., Arroll B., and Shepherd J. Lipids and CVD management: towards a global consensus. Eur Heart J 26 (2005) 2224-2231
17. Kelly G.S. Seasonal variations of selected cardiovascular risk factors. Altern Med Rev 10 (2005) 307-320
18. Fitzpatrick T.B. Soleil et peau. J Med Esthet 2 (1975) 33-34
19. Pathak M.A., and Fitzpatrick T.B. Preventive treatment of sunburn, dermatoheliosis and skin cancer with sun-protective agents. In: Fitzpatrick T.B., Eisen A.Z., Wolff K., Freedberg I.M., and Austen K.F. (Eds). Dermatology in general medicine (1993), McGraw-Hill, New York 1689-1717
20. ISO 17166 CIE S 007/E. Erythema reference action spectrum and standard erythema dose (1999), International Organization for Standardization, Geneva 4
21. Chen T.C., Turner A.K., and Holick M.F. Methods for the determination of the circulating concentration of 25-hydroxyvitamin D. J Nutr Biochem 1 (1990) 315-319
22. Hughes T.A., Gaber A.O., and Montgomery C.E. Plasma distribution of cyclosporine within lipoproteins and "in vitro" transfer between very-low-density lipoproteins, low-density lipoproteins, and high-density lipoproteins. Ther Drug Monit 13 (1991) 289-295
23. Hughes T.A., Moore M.A., Neame P., Medley M.F., and Chung B.H. Rapid quantitative apolipoprotein analysis by gradient ultracentrifugation and reversed-phase high performance liquid chromatography. J Lipid Res 29 (1988) 363-376
24. Shen M.M., Krauss R.M., Lindgren F.T., and Forte T.M. Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res 22 (1981) 236-244
25. Fruchart J.C., De Geteire C., Delfly B., and Castro G.R. Apolipoprotein A-I-containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis risk. Atherosclerosis 110 Suppl (1994) S35-S39
26. Roheim P.S., and Asztalos B.F. Clinical significance of lipoprotein size and risk for coronary atherosclerosis. Clin Chem 41 (1995) 147-152
27. Fruchart J.C., and Ailhaud G. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clin Chem 38 (1992) 793-797
28. Inoue T., Uchida T., Kamishirado H., Takayanagi K., Hayashi T., Morooka S., et al. Remnant-like lipoprotein particles as risk factors for coronary artery disease in elderly patients. Horm Metab Res 36 (2004) 298-302
29. Auwerx J., Bouillon R., and Kesteloot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb 12 (1992) 671-674
30. John W.G., Noonan K., Mannan N., and Boucher B.J. Hypovitaminosis D is associated with reductions in serum apolipoprotein A-I but not with fasting lipids in British Bangladeshis. Am J Clin Nutr 82 (2005) 517-522
31. Slominski A., Zjawiony J., Wortsman J., Semak I., Stewart J., Pisarchik A., et al. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem 271 (2004) 4178-4188
32. Duriez P., and Fruchart J.C. High-density lipoprotein subclasses and apolipoprotein A-I. Clin Chim Acta 286 (1999) 97-114
33. Rinninger F., Brundert M., Budzinski R.M., Fruchart J.C., Greten H., and Castro G.R. Scavenger receptor BI (SR-BI) mediates a higher selective cholesteryl ester uptake from LpA-I compared with LpA-I:A-II lipoprotein particles. Atherosclerosis 166 (2003) 31-40
34. de Beer M.C., Castellani L.W., Cai L., Stromberg A.J., de Beer F.C., and van der Westhuyzen D.R. ApoA-II modulates the association of HDL with class B scavenger receptors SR-BI and CD36. J Lipid Res 45 (2004) 706-715
35. Hedrick C.C., and Lusis A.J. Apolipoprotein A-II: a protein in search of a function. Can J Cardiol 10 (1994) 453-459
36. Rogers J., Harding C., Mayo A., Banks J., and Rawlings A. Stratum corneum lipids: the effect of ageing and the seasons. Arch Dermatol Res 288 (1996) 765-770
37. Lehmann B., Genehr T., Knuschke P., Pietzsch J., and Meurer M. UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol 117 (2001) 1179-1185
38. Nemanic M.K., Whitney J., Arnaud S., Herbert S., and Elias P.M. Vitamin D3 production by cultured human keratinocytes and fibroblasts. Biochem Biophys Res Commun 115 (1983) 444-450
39. Bae S.H., Lee J.N., Fitzky B.U., Seong J., and Paik Y.K. Cholesterol biosynthesis from lanosterol. Molecular cloning, tissue distribution, expression, chromosomal localization, and regulation of rat 7-dehydrocholesterol reductase, a Smith-Lemli-Opitz syndrome-related protein. J Biol Chem 274 (1999) 14624-14631
40. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81 (2006) 353-373
41. Stephenson A., Brotherwood M., Robert R., Atenafu E., Corey M., and Tullis E. Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis. Am J Clin Nutr 85 (2007) 1307-1311
42. Hoppough S. Shades of skin care: understanding the risk of skin cancer in all skin colors. [online]. [Internet resource] [cited 2007 June 14]; Available from: (2000). http://www.healthteam.msu.edu/imc/modules/Shades%20of%20Skin%20Care/skin/
43. Tangpricha V., Koutkia P., Rieke S.M., Chen T.C., Perez A.A., and Holick M.F. Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr 77 (2003) 1478-1483